Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Blue Wave Investments Celebrates Receiving 5-Star Reviews on Google for its Hassle-Free ‘Sell Your House Fast Southern California’ Service
-
VCI Global Expands AI Footprint with US$33 Million in AI Infrastructure Contracts Across Three Enterprises
-
LexisNexis Announces Legal Industry’s First Voice AI Assistant to Simplify Legal Workflows, Surface Insights, and Complete Legal Work Faster
-
Sesame, America’s Low-Cost Leader in Healthcare, Streamlines Access for Eligible Patients to Lilly’s Obesity Medicine Zepbound
-
Lakeside Hire Celebrates Feefo Platinum Trusted Service Award
-
EZCORP Announces Private Offering of $300,000,000 of Senior Notes Due 2032
-
Hooker Furnishings to Exit Georgia Distribution Center
-
PRISM MarketView Spotlights NextNRG’s Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments
-
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
-
UA Multimedia Announces Leadership Transition and Change of Control
-
Actelis Networks Reports Full Year 2024 Results: Revenue Sees 38% Growth Reaching $7.8 Million, 125% Increase in Gross Margin, Loss Per Share Shrinks by 67% to $0.85
-
Icon Energy Corp. Announces Fleet Expansion with and Time Charter Contract for a 2020-Built, Scrubber-Fitted, Eco, Ultramax, Dry Bulk Carrier
-
Standard Lithium Reports Results for Six Month Fiscal Period Ended December 31, 2024
-
Salvatore Castagna Revolutionizes Passive Income with Customizable Cryptocurrency Devices
-
Shiba ZK to Launch ICO, Blending Meme Culture with Cutting-Edge Blockchain Technology
-
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After La
-
Lexbe CoPilot GenAI Now Included with the Lexbe eDiscovery Platform at No Additional Cost
-
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
-
Roper Technologies to acquire CentralReach
-
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
-
Fluent, Inc. Announces $5.0 Million Private Offering
-
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Data Storage Corporation Schedules Fiscal 2024 Business Update Conference Call
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Chain Reaction’s Disruptive ASIC Technologies Enable Innovations with Industry-Leading Customers and Partners for Next-Generation Bitcoin Mining
-
AITX Receives First Multi-Unit Expansion Order from a Top Client
-
Mongolian Mining Corporation Announces 2024 Annual Results
-
Share buy-back program
-
Verizon to redeem debt securities on April 23, 2025
-
Flutter Entertainment: Updated Reportable Segment Financial Data
-
Flutter Entertainment: Updated Reportable Segment Financial Data
-
Ocean Power Technologies Awarded Contract for Delivery of AI Capable Buoy in the USA
-
Transactions in connection with share buyback programme
-
Net Asset Value(s)
-
Close of Offers to Further Applications
-
Court Orders Reduction in Damages in Case Against Wabash
-
Steele Foundation Honored with Prestigious 2025 WBC Craftsmanship Award
-
Invesco Ltd: Form 8.3 - Direct Line Insurance Group PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Aura Minerals Announces Renewal of Normal Course Issuer Bid and Concurrent Buyback Program for Brazilian Depositary Receipts
-
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.6 Million
-
WillScot to Nominate Dominick Zarcone as New Independent Director
-
FTC Solar to Announce Fourth Quarter and Full Year 2024 Financial Results Monday, March 31, 2025
-
Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting
-
Rio2 Announces Receipt of Second Deposit of US$25 Million From Fenix Gold Stream
-
Kratos Defense & Security Solutions Added to S&P SmallCap 600 Index
-
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
-
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
-
Ep3Oil, Inc. Announces Letter To Shareholders
-
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
